Glycosylation with Glycosyl ortho-Alkynylbenzoates
FULL PAPER
72.8, 70.8, 68.9, 62.6, 30.5, 22.0, 19.4, 13.6 ppm; HRMS (MALDI): m/z:
calcd for C47H40O11 [M+Na]+: 803.2463; found: 803.2479.
amides, superior a-selective glycosidation of 2-deoxy sugars,
and b-selective sialylation. Further evidence of the efficacy
of the present method is provided by its application to the
efficient synthesis of the complex cyclic triterpene glycoside
43, in that a novel chemoselective glycosylation of carboxyl-
ic acid and a new one-pot sequential glycosylation sequence
have been realized. However, the working mechanism of
this new glycosylation protocol has not yet been validated,
nor has a new solution for the general issue of the a/b selec-
tivity been provided.
Compound 3b (Conditions B): A solution of lactol 1b (2.16 g, 4.0 mmol),
2
(970 mg, 4.8 mmol), DMAP (488 mg, 4.0 mmol), EDCI (955 mg,
5.0 mmol), and DIPEA (1.3 mL, 7.2 mmol) in dry CH2Cl2 (4 mL) was
stirred for 3 h at RT, and was then diluted with CH2Cl2. The resulting
mixture was washed with saturated NaHCO3 and brine, respectively. The
filtrates were concentrated. The residue was purified by silica gel column
chromatography (hexane/ethyl acetate 10:1) to provide 3b as a white
solid (2.82 g, 97%; b/a=1:1.2).
Compound 3i (Conditions C): Triethylamine (0.58 mL, 4.18 mmol) and
2,4,6-trichlorobenzoylchloride (0.52 mL, 3.34 mmol) were added to a so-
lution of 2 (338 mg, 1.67 mmol) in toluene at RT. After stirring at RT for
2 h, compound 1i (820 mg, 1.67 mmol) in toluene was added, followed by
the addition of DMAP (510 mg, 4.18 mmol) in toluene. After stirring for
an additional 1 h, the mixture was concentrated. The residue was subject-
ed to flash chromatography on silica gel (CH2Cl2/methanol 120:1) to pro-
vide 3i as a white solid (992 mg, 88%; b/a =10:1). A small portion of
the a,b-anomers were separated and characterized. Compound 3ib:
[a]2D0 =ꢀ12.5 (c=0.6 in CH2Cl2); 1H NMR (300 MHz, CDCl3): d=7.92–
7.91 (m, 1H), 7.55–7.53 (m, 1H), 7.50–7.47 (m, 1H), 7.38–7.37 (m, 1H),
5.41–5.36 (m, 3H), 5.13–5.10 (m, 1H), 4.52 (dd, J=13.0, 2.67 Hz, 1H),
4.22–4.15 (m, 3H), 3.82 (s, 3H), 2.73 (dd, J=13.6, 5.1 Hz, 1H), 2.45 (t,
J=7.1 Hz, 2H), 2.20 (dd, J=13.5, 11.6 Hz, 1H), 2.16 (s, 3H), 2.03 (s,
3H), 1.88 (s, 3H), 1.87 (s, 3H), 1.62–1.58 (m, 2H), 1.51–1.46 (m, 2H),
Experimental Section
General procedures: Please see the Supporting Information.
Preparation of compound 2: [PdCl2ACHTUNTGRNEUNG(PPh3)2] (4.20 g, 6.0 mmol), CuI
(1144 mg, 6.0 mmol), and PPh3 (3.14 g, 12.0 mmol) were added to methyl
2-iodobenzoate (18.0 mL, 120.0 mmol) in dry iPr2NH (180 mL). After
stirring at RT for 1 h under an Ar atmosphere, 1-hexyne (20.8 mL,
180.0 mmol) was slowly added at 08C. The mixture was allowed to stir at
RT for 18 h (or at 608C for 6 h) and saturated NH4Cl (400 mL) was
added. After vigorously stirring for 30 min, petroleum ether (400 mL)
was added and the phases separated. The aqueous layer was extracted
with hexane/EtOAc (100:1), the combined organic layers were washed
with H2O and brine, dried over Na2SO4, then concentrated. The crude
product was purified by column chromatography on silica gel (hexane/
EtOAc 50:1) to provide methyl 2-hex-1-ynyl benzoate as a yellow oil
(25.9 g, 99%). This oil was dissolved in THF (500 mL) and aqueous
NaOH (1n, 500 mL) was added. After stirring at 508C for 12 h, the solu-
tion was cooled to 08C and then acidified with concentrated HCl. After
removal of THF by rotary evaporation, the residue was contracted with
CH2Cl2 five times. The combined organic layers were dried over Na2SO4
and then concentrated to give 2[58] as a yellow oil (24.2 g, 100%), which
became a light yellow solid when stored at ꢀ188C. 1H NMR (300 MHz,
CDCl3): d=8.07 (d, J=7.8 Hz, 1H), 7.57–7.44 (m, 2H), 7.36 (t, J=
7.2 Hz, 1H), 2.50 (t, J=6.6 Hz, 2H), 1.70–1.45 (m, 4H), 0.96 ppm (t, J=
6.9 Hz, 3H).
0.95 ppm (t, J=7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): d
= 170.9,
170.6, 170.2, 170.0, 166.3, 163.4, 134.7, 132.4, 130.4, 130.0, 127.3, 125.2,
98.2, 97.0, 79.0, 72.9, 71.1, 68.6, 67.6, 62.1, 53.2, 49.5, 36.1, 30.6, 23.1, 22.0,
20.8, 20.7, 19.5, 13.6 ppm; HRMS (ESI): m/z: calcd for C33H41NO14Na
[M+Na]+: 698.2419; found 698.2426. Compound 3ia: [a]2D0 =+3.1 (c=1.2
1
in CHCl3); H NMR (300 MHz, CDCl3): d=7.92–7.91 (m, 1H), 7.52–7.51
(m, 1H), 7.48–7.44 (m, 1H), 7.36–7.32 (m, 1H), 5.82 (d, J=9.8 Hz, 1H),
5.41 (dd, J=6.3, 2.2 Hz, 1H), 5.27–5.24 (m, 1H), 5.17 (td, J=11.8, 5.0 Hz,
1H), 4.69 (dd, J=10.8, 2.3 Hz, 1H), 4.42 (dd, J=12.4, 2.8 Hz, 1H), 4.25
(q, J=10.2 Hz, 1H), 4.13 (dd, J=12.4, 6.0 Hz, 1H), 3.80 (s, 3H), 2.78
(dd, J=13.3, 5.0 Hz, 1H), 2.47 (t, J=7.1 Hz, 2H), 2.27 (dd, J=13.2,
11.2 Hz, 1H), 2.11 (s, 3H), 2.10 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 1.91 (s,
3H), 1.64–1.58 (m, 2H), 1.53–1.47 (m, 2H), 0.95 ppm (t, J=7.3 Hz, 1H);
13C NMR (75 MHz, CDCl3): d=170.8, 170.5, 170.3, 170.0, 168.3, 163.5,
134.3, 132.1, 130.8, 130.1, 127.1, 125.0, 96.6, 96.4, 78.7, 73.8, 70.4, 68.8,
67.6, 62.1, 52.8, 49.0, 36.7, 30.6, 23.1, 22.0, 20.8, 20.7, 20.6, 19.4, 13.5 ppm;
HRMS (ESI): m/z: calcd for C33H41NO14Na [M+Na]+: 698.2419; found:
698.2416.
Typical procedures for the preparation of glycosyl ortho-hexynylben-
zoates
Typical procedure for the glycosylation with glycosyl ortho-hexynylben-
Compound 3b (Conditions A): A solution of lactol 1b (1.08 g, 2.0 mmol),
2 (485 mg, 2.4 mmol), DMAP (366 mg, 3.0 mmol), and DCC (618 mg,
3.0 mmol) in dry CH2Cl2 (3 mL) was stirred for 3 h at RT, and was then
diluted with CH2Cl2. The resulting mixture was filtered through Celite.
The filtrates were washed with saturated NaHCO3 solution and then con-
centrated in vacuum. The residue was purified by silica gel column chro-
matography (hexane/ethyl acetate 10:1) to provide 3b as a white solid
(1.42 g, 98%; b/a=1.4:1). A small portion of the a,b-anomers were sepa-
rated and characterized. Compound 3ba: [a]2D7 =98.3 (c=4.1 in CHCl3);
1H NMR (300 MHz, CDCl3): d=8.09–7.22 (m, 24H), 6.93 (d, J=3.3 Hz,
1H), 6.32 (t, J=10.2 Hz, 1H), 5.90 (t, J=9.9 Hz, 1H), 5.73 (dd, J=10.2,
2.7 Hz, 1H), 4.75–4.64 (m, 2H), 4.52 (dd, J=12.3, 3.9 Hz, 1H), 2.49 (m,
2H), 1.58 (m, 2H), 1.45 (m, 2H), 0.91 ppm (t, J=7.5 Hz, 1H); 13C NMR
(75 MHz, CDCl3): d=166.0, 165.7, 165.3, 165.1, 163.9, 135.0, 133.5, 133.4,
133.3, 133.1, 132.4, 130.7, 129.9, 129.8, 129.7 (3C), 129.4, 128.8, 128.6,
128.5, 128.4, 128.3 (2C), 127.3, 125.3, 97.2, 90.0, 79.5, 70.6, 70.4, 70.4, 68.8,
62.3, 30.6, 22.0, 19.5, 13.6 ppm; HRMS (MALDI): m/z: calcd for
zoates as donors (3b+4a!8):
A freshly prepared solution of
PPh3AuOTf in CH2Cl2 (0.05n, 0.2 mL) was added to a mixture of o-hexy-
nylbenzoate 3b (94 mg, 0.12 mmol), cholesterol 4a (39 mg, 0.10 mmol),
and 4 ꢃ MS in dry CH2Cl2 (2 mL).[32,59] After stirring at RT for 3 h, the
mixture was filtered through Celite. The filtrates were concentrated. The
residue was purified by silica gel column chromatography (hexane/ethyl
acetate 10:1) to provide 8[60] as a white solid (95 mg, 98%).
Glycosylations in the total synthesis of the cyclic triterpene saponin 43
Chemoselective glycosylation (44+46!50): DBU (0.85 mL, 5.82 mmol)
was added to
a stirred mixture of glycosyl benzoate 46 (1.62 g,
2.91 mmol), oleanolic acid 44 (1.57 g, 3.44 mmol), and 4 ꢃ MS in CH2Cl2
(25 mL) at RT. After stirring for 20 min, BF3·Et2O (1.01 mL, 8.73 mmol)
and a freshly prepared solution of Ph3PAuOTf in CH2Cl2 (0.06m, 5 mL)
was added sequentially. After stirring overnight, the mixture was filtered
through Celite, and the filtrates were concentrated. The resulting residue
was purified by silica gel column chromatography (toluene/EtOAc 30:1)
to afford 50 (1.70 g, 72%) as a white foam. [a]2D0 =30.3 (c=1.0 in CHCl3);
1H NMR (400 MHz, CDCl3): d=7.34–7.16 (m, 10H), 5.63 (d, J=4.5 Hz,
1H), 5.30 (d, J=3.3 Hz, 1H), 5.25 (t, J=5.1 Hz, 1H), 4.66 (s, 2H), 4.59
(s, 2H), 4.13–4.07 (m, 1H), 3.76–3.68 (m, 2H), 3.52 (dd, J=2.4, 11.4,
1H), 3.20 (brs, 1H), 2.85 (dd, J=5.1, 14.4 Hz, 1H), 2.04, 1.12, 0.99, 0.90,
0.87, 0.78, 0.76 ppm (s, each 3H); 13C NMR (75 MHz, CDCl3): d=175.8,
169.1, 143.3, 138.0, 137.9, 128.3, 128.2, 127.8, 127.7, 127.6, 127.4, 122.7,
91.2, 78.9, 75.1, 72.1, 71.7, 71.3, 69.3, 61.2, 55.3, 47.6, 46.9, 45.8, 41.8, 41.1,
C47H40O11 [M+Na]+: 803.2463; found: 803.2462. Compound 3bb: [a]2D7
=
1
54.2 (c=4.5 in CHCl3); H NMR (300 MHz, CDCl3): d=8.06–7.22 (m,
24H), 6.35 (d, J=7.8 Hz, 1H), 6.03 (t, J=9.3 Hz, 1H), 5.84 (m, 2H), 4.69
(dd, J=12.3, 2.1 Hz, 1H), 4.53 (dd, J=12.0, 4.2 Hz, 1H), 4.44 (m, 1H),
2.46 (t, J=6.6 Hz, 2H), 1.61 (m, 2H), 1.49 (m, 2H), 0.94 ppm (t, J=
7.2 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=166.0, 165.6, 165.0 (2C),
163.3, 134.5, 133.4 (2C), 133.2, 133.0, 132.4, 130.8, 129.7 (2C), 129.4,
129.0, 128.6, 128.5, 128.3 (2C), 128.2, 127.1, 125.8, 97.3, 92.4, 78.9, 73.0,
Chem. Eur. J. 2010, 16, 1871 – 1882
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1879